Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with H-pylori infection

被引：0

作者：

Cestari, R

Corti, G

Formenti, A

Galli, F

Gatti, M

Marotta, F

Milesi, F

Paterlini, A

Piubello, W

Ravelli, P

Tonini, G

Ubiali, P

Valenghi, D

Fina, P

Olivieri, A

Tosatto, R

机构：

[1] Univ Brescia, I-25121 Brescia, Italy

[2] Hosp Desio, Desio, Italy

[3] Hosp Cantu, Cantu, Italy

[4] Hosp Saronno, Saronno, Italy

[5] Hosp Giussano, Giussano, Italy

[6] Hosp Como, Como, Italy

[7] Hosp Treviglio, Treviglio, Italy

[8] Hosp Brescia, Brescia, Italy

[9] Hosp Salo, Salo, Italy

[10] Hosp Alzano Lombardo, Alzano Lombardo, Italy

[11] Hosp Lovere, Lovere, Italy

来源：

GUT | 1998年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A83 / A84

页数：2

共 50 条

[1] Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection
Cestari, R
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) : 991 - 996
[2] Ranitidine bismuth citrate (RBC) is more effective than omeprazole in the eradication of H-pylori when co-prescribed with clarithromycin
Pare, P
Romaozinho, J
Bardhan, KD
French, PC
Roberts, PM
[J]. GASTROENTEROLOGY, 1997, 112 (04) : A251 - A251
[3] A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H-pylori infection
van Zanten, SJOV
Chiba, N
Barkun, AN
Fallone, CA
Farley, A
Cockeram, A
Dallaire, C
Simms, L
Nicholls, B
[J]. GASTROENTEROLOGY, 2001, 120 (05) : A586 - A586
[4] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori
Laine, L
Estrada, R
Trujillo, M
Emami, S
[J]. GUT, 1997, 41 : A103 - A104
[5] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori (HP).
Laine, L
Estrada, R
Trujillo, M
Emami, S
[J]. GASTROENTEROLOGY, 1997, 112 (04) : A192 - A192
[6] Ten day triple therapy with Ranitidine bismuth citrate (RBC), amoxicillin and clarithromycin in the eradication of H-pylori.
Vakil, N
Cutler, AF
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A317 - A317
[7] Metronidazole resistance does not influence the efficacy of triple therapy with ranitidine bismuth citrate (RBC), clarithromycin (CLA) and metronidazole (MET) for H-pylori (Hp) infection.
van der Wouden, EJ
Thijs, JC
van Zwet, AA
Kooy, A
Kleibeuker, JH
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A323 - A323
[8] The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection
Van der Wouden, EJ
Thijs, JC
van Zwet, AA
Kooy, A
Kleibeuker, JH
[J]. GUT, 1998, 43 : A86 - A86
[9] Double therapy with ranitidine bismuth citrate (RBC) and clarithromycin during two weeks, has lower efficacy than triple therapy with RBC, clarithromycin and amoxicillin during one week in the eradication of H. pylori infection.
Hergueta, P
Rojas, M
Romero, R
Gomez, BJ
Pellicer, FJ
Herrerias, JM
[J]. GASTROENTEROLOGY, 2000, 118 (04) : A1245 - A1245
[10] Ranitidine bismuth citrate (RBC) or omeprazole (O) with clarithromycin (C) and amoxycillin (A) for one week in the eradication of H-pylori
Cabooter, M
Dekkers, CPM
Theodors, A
Vanweerts, S
[J]. GASTROENTEROLOGY, 1999, 116 (04) : A345 - A345

← 1 2 3 4 5 →